Skip to main content

Table 1 The Child-Pugh class level, HBV DNA level and full blood test analysis corresponding to pembrolizumab and lenvatinib combination therapy

From: Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report

DateALB(g/l)HEPTINRAscitesT-BILScoreHBV-DNAWBC(10^9/L)GR(10^9/L)HGB(g/L)PLT(10^9/L)
17.11.2730.4N15.31.35Y16.4823701.30.5811242
18.2.731.6N15.41.3N17.37<301.450.8111843
18.3.233.0N15.61.31N23.67<301.890.9912648
18.4.825N20.41.73N32.71038.71.620.6712721
18.6.1126N16.61.4N31.17<201.210.5811023
18.7.929.7N16.51.39N25.37/1.260.7111334
18.7.3130.3N16.61.4N30.87/1.420.7212021
18.8.2229.2N16.21.36N20.57<200.90.4210625
18.11.931.8N15.41.29N21.67<201.330.6911727
\